Skip to main content
release_alert
Welcome to the new Scholars 3.0! Read about new features and let us know what you think.
cancel
medRxiv

Clinical Trial Evidence Supporting FDA Approval of Novel Therapeutic Agents Over Three Decades, 1995-2017: Cross-Sectional Analysis

Publication ,  Preprint
Zhang, A; Puthumana, J; Downing, N; Shah, N; Krumholz, H; Ross, J
2019

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

DOI

Publication Date

2019
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Zhang, A., Puthumana, J., Downing, N., Shah, N., Krumholz, H., & Ross, J. (2019). Clinical Trial Evidence Supporting FDA Approval of Novel Therapeutic Agents Over Three Decades, 1995-2017: Cross-Sectional Analysis. medRxiv. https://doi.org/10.1101/19007047
Zhang, Audrey, Jeremy Puthumana, Nicholas Downing, Nilay Shah, Harlan Krumholz, and Joseph Ross. “Clinical Trial Evidence Supporting FDA Approval of Novel Therapeutic Agents Over Three Decades, 1995-2017: Cross-Sectional Analysis.” MedRxiv, 2019. https://doi.org/10.1101/19007047.

DOI

Publication Date

2019